Table 3.

Multifactorial logistic regression analysis of the gastrointestinal adverse reactions caused by glucagon-like peptide-1 receptor agonists.

	Primary model			Final model
	β	OR (95%CI)	p-value	β	OR (95%CI)	p-value
Gender (% women)	1.05	2.86 (1.47–5.60)	0.002	0.84	2.32 (1.42–3.80)	<0.001
History of gastrointestinal disorders	1.59	4.92 (2.39–10.12)	<0.001	1.83	6.22 (3.49–11.11)	<0.001
Age (years)	0.05	1.06 (1.02–1.09)	<0.001	0.05	1.05 (1.04–1.07)	<0.001
No. of combined oral drugs	0.66	1.94 (1.63–2.31)	<0.001	0.61	1.84 (1.62–2.10)	<0.001
eGFR (ml/min/1.73 m2)	0.02	1.02 (1.00–1.04)	0.128
BMI (kg/m2)	0.06	1.06 (0.99–1.14)	0.089